Replimune (REPL) Cash from Investing Activities (2017 - 2026)

Replimune (REPL) has 10 years of Cash from Investing Activities data on file, last reported at $86.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 1223.45% year-over-year to $86.5 million; the trailing twelve-month figure through Mar 2026 stood at $310.8 million (up 1406.28% YoY), and the FY2026 full-year result was $310.8 million, up 1406.28% from the prior year.
• Cash from Investing Activities grew to $86.5 million in Q1 2026, from $75.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $86.5 million in Q1 2026 to a low of -$125.1 million in Q4 2022.
• A 5-year average of $14.0 million and a median of $7.4 million in 2023 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities slumped 832.2% in 2022 and surged 35130.56% in 2023, its largest moves.
• Tracing REPL's Cash from Investing Activities over 5 years: stood at -$125.1 million in 2022, then jumped by 143.13% to $54.0 million in 2023, then sank by 185.85% to -$46.3 million in 2024, then surged by 262.18% to $75.1 million in 2025, then grew by 15.16% to $86.5 million in 2026.
• Business Quant data shows REPL's Cash from Investing Activities at $86.5 million in Q1 2026, $75.1 million in Q4 2025, and $84.2 million in Q3 2025.